Literature DB >> 12816848

Making decisions about hormone replacement therapy: preparations containing oestrogen should not be given during treatment for breast cancer.

Christopher P Hinton, Claire Coventry, Bridget Borrowclough.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12816848      PMCID： PMC1126272          DOI： 10.1136/bmj.326.7403.1398

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

Review 1.  Making decisions about hormone replacement therapy.

Authors:  Janice Rymer; Ruth Wilson; Karen Ballard
Journal:  BMJ       Date:  2003-02-08

2.  Multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer: an intergroup study.

Authors:  C W Taylor; S Green; W S Dalton; S Martino; D Rector; J N Ingle; N J Robert; G T Budd; J C Paradelo; R B Natale; J D Bearden; J A Mailliard; C K Osborne
Journal:  J Clin Oncol       Date:  1998-03       Impact factor: 44.544

3.  Ovarian ablation versus goserelin with or without tamoxifen in pre-perimenopausal patients with advanced breast cancer: results of a multicentric Italian study.

Authors:  F Boccardo; A Rubagotti; A Perrotta; D Amoroso; M Balestrero; A De Matteis; P Zola; P Sismondi; G Francini; R Petrioli
Journal:  Ann Oncol       Date:  1994-04       Impact factor: 32.976
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.